Monogram Technologies Stock Soars 74% On Zimmer Biomet Acquisition

(RTTNews) - Monogram Technologies Inc. (MGRM) shares surged 74.16 percent to $5.73 on Monday after announcing its acquisition by Zimmer Biomet Holdings in a cash-and-contingent deal valued up to $16.41 per share. The upfront payment of $4.04 per share reflects an equity value of approximately $177 million, with an additional $12.37 per share tied to future development, regulatory, and revenue milestones through 2030.

The stock opened at $5.51 and hit an intraday high of $6.02, with volume soaring to over 12.5 million shares compared to its average of around 60,000 on the Nasdaq.

Monogram's FDA-cleared robotic total knee arthroplasty technology and pipeline of autonomous surgical solutions will enhance Zimmer Biomet's ROSA Robotics platform. MGRM is now trading near its 52-week high of $6.02.